EPL (500135) Q2 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 24/25 earnings summary
18 Jun, 2026Executive summary
Q2 FY25 saw strong performance with revenue up 8.4% year-over-year, led by 21% growth in Europe and robust results in Americas and EAP.
EBITDA margin improved to 20%, up 188 bps, with absolute EBITDA up 19.7% year-over-year.
PAT increased by 72% year-over-year, driven by EBITDA growth and stable depreciation and interest costs.
Interim dividend of INR 2.50 per share declared for FY25.
Board approved unaudited financial results and noted changes in board composition.
Financial highlights
Q2 FY25 consolidated revenue was INR 10,862 million, up 8.4% year-over-year.
EBITDA reached INR 2,167 million, up 19.7% year-over-year; margin at 20%.
PAT was INR 870 million, up 72.3% year-over-year; EPS at 2.73, up 73%.
Net debt reduced to INR 5,949 million; ROCE at 16.5%, up 260 bps year-over-year.
Interim dividend of INR 2.50 per share declared.
Outlook and guidance
Targeting sustainable double-digit revenue growth and EBITDA margins above 20%.
Aggressive expansion in 'Personal Care & Beyond' and Brazil, with continued focus on sustainability and margin expansion.
No change to FY27 aspirational targets; focus remains on delivering current guidance.
Board and auditors did not raise any material uncertainties or misstatements in the outlook.
Latest events from EPL
- Double-digit revenue and profit growth, margin expansion, and interim dividend declared.500135
Q2 25/2618 Jun 2026 - Strong revenue, margin, and profit growth, with global expansion and sustainability focus.500135
Q4 24/2518 Jun 2026 - Double-digit growth, margin expansion, and sustainability-led gains with improved debt metrics.500135
Q1 24/2518 Jun 2026 - Q4FY26 saw double-digit revenue growth, strong margins, and a major merger announcement.500135
Q4 25/2614 May 2026 - $1B merger forms an emerging markets packaging leader with major synergies and global reach.500135
M&A announcement30 Mar 2026 - Double-digit revenue and EBITDA growth, led by beauty and cosmetics, with improved ROCE.500135
Q3 25/2613 Feb 2026 - EBITDA margin hit 20.3% with robust profit growth and expansion in key segments.500135
Q3 24/2523 Dec 2025 - Double-digit growth, margin expansion, and strong beauty/cosmetics momentum drive outlook.500135
Q1 25/2623 Nov 2025